Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity.
about
Cellular robustness conferred by genetic crosstalk underlies resistance against chemotherapeutic drug doxorubicin in fission yeastThe tell-tale heart: molecular and cellular responses to childhood anthracycline exposureCardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological preventionCoenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics.Should patients undergoing chemotherapy and radiotherapy be prescribed antioxidants?Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?Kidney tissue targeted metabolic profiling of glucocorticoid-induced osteoporosis and the proposed therapeutic effects of Rhizoma Drynariae studied using UHPLC/MS/MS.Long-term protective effects of the angiotensin receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress and myocardial dysfunction.Effect of coenzyme-q10 on Doxorubicin-induced nephrotoxicity in ratsLong-term, up to 18 months, protective effects of the angiotensin II receptor blocker telmisartan on Epirubin-induced inflammation and oxidative stress assessed by serial strain rate.Doxorubicin inactivates myocardial cytochrome c oxidase in rats: cardioprotection by Mito-QLack of effect of coenzyme q10 on doxorubicin cytotoxicity in breast cancer cell cultures.Trastuzumab and doxorubicin-related cardiotoxicity and the cardioprotective role of exercise.Natural and synthetic antioxidants: an updated overview.Heart failure and chemotherapeutic agents.Efficacy and Interaction of Antioxidant Supplements as Adjuvant Therapy in Cancer Treatment: A Systematic Review.New biomarkers for early detection of cardiotoxicity after treatment with docetaxel, doxorubicin and cyclophosphamide.Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.Anticancer DNA intercalators cause p53-dependent mitochondrial DNA nucleoid re-modellingIntegrative healthcare symposium: cancer and chronic lyme disease.Protective effect of Co-enzyme Q10 On doxorubicin-induced cardiomyopathy of rat hearts.The effects of ubiquinone (CoQ10) on heart tissue in cardiac toxicity related to organophosphate poisoning.Anandamide preserves cardiac function and geometry in an acute doxorubicin cardiotoxicity rat model.Electrocardiographic and hemodynamic effects of coenzyme Q10 in healthy individuals: a double-blind, randomized controlled trial.Coenzyme Q10 protects renal proximal tubule cells against nicotine-induced apoptosis through induction of p66shc-dependent antioxidant responses.The Central Role of Amino Acids in Cancer Redox Homeostasis: Vulnerability Points of the Cancer Redox Code.Chemotherapeutic-Induced Cardiovascular Dysfunction: Physiological Effects, Early Detection-The Role of Telomerase to Counteract Mitochondrial Defects and Oxidative Stress.
P2860
Q21133734-17E14723-965B-40FA-84FA-8CC1AE394287Q26823592-29488D94-126C-46E1-8F76-7CE9EF349849Q33574045-5F3B3944-300A-4F25-9EDC-C0B79C4F0A3AQ34503981-CD1EDFBE-8D92-44E4-A8BF-4811443B1812Q34564943-90EB68B8-52EA-4385-947E-C5503986C9B2Q34782021-1A7EC4E7-FFE6-49AC-A5B5-0E8874B26084Q35174172-20188C67-8B55-465F-84CB-EF726848553BQ36230936-6EA81FD3-5731-4D63-86C2-A55F435C08F9Q36499369-2D5BD1FC-3665-4108-8B1F-4B23BB5D5FC9Q36878219-513B748D-4441-476D-AD4E-808BB013748CQ37279228-08FB89FA-944F-4F97-A1B6-FD6B6E61B63EQ37341831-7E3C6E8F-30F0-4B4F-959F-C79934EE2A26Q37378906-47FA9D8D-8E4C-4DDE-83B4-3CEC8D02B1B9Q37788234-85CBDAB7-AB80-40A8-969B-8B931435E68CQ38559133-5BC31594-9F53-4E74-AEC2-AA6558081F80Q38616751-9BA82DE9-F6DE-49D6-9F8D-4E4192B66D00Q39005990-B1A0E170-67EB-4F42-97B0-0E275C18C190Q39400621-0E6E5D3A-6118-435A-9AFA-6A07F2C52A20Q39811992-C07DB3E0-61AC-4948-B0B4-E407B880AF7CQ41452535-746DC5A0-292C-4540-98D1-8EBCD86ADA24Q42698011-AAF848D9-3230-49AA-865A-F2935BEDA837Q45825078-96FC4A46-E06E-4075-A188-C5653EFFD064Q46171847-1F872C8C-6F42-49CA-9FA6-7EF53758762EQ46438608-1B90474F-12C7-4984-8BB8-BB57C9535FA9Q46473480-13221A56-91A0-4521-B14E-3DFAC22F4A1AQ49369970-E5CD5BE9-3FEA-48D1-88DC-9832BDE09039Q54959206-69B54C12-586E-42BA-A882-AE177D2E3FB7
P2860
Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity.
@ast
Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity.
@en
type
label
Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity.
@ast
Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity.
@en
prefLabel
Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity.
@ast
Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity.
@en
P2860
P356
P1476
Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity.
@en
P2093
Kenneth A Conklin
P2860
P304
P356
10.1177/1534735405276191
P577
2005-06-01T00:00:00Z